Recombinant cIAP1 Antibody - Primary antibody, specific to BIRC2, Rabbit IgG

    Application:
  • IF/ICC
  • WB
Features and benefits
  • Host species: Rabbit
  • Species reactivity(Reacts with): Human
  • Isotype: Rabbit IgG
  • Conjugation: Unconjugated
Item Number
Ab096509
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab096509-10μl
10μl
In stock
$66.90
Ab096509-50μl
50μl
In stock
$189.90
Ab096509-100μl
100μl
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$299.90
Ab096509-1ml
1ml
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,699.90

Recombinant; Rabbit anti Human cIAP1 Antibody; WB, IF, ICC; Unconjugated

Basic Description

Product NameRecombinant cIAP1 Antibody - Primary antibody, specific to BIRC2, Rabbit IgG
SynonymsAPI 1 antibody | API1 antibody | Apoptosis inhibitor 1 antibody | Baculoviral IAP repeat containing 2 antibody | Baculoviral IAP repeat containing protein 2 antibody | Baculoviral IAP repeat-containing protein 2 antibody | BIRC 2 antibody | BIRC2 antibody
Specifications & PurityExactAb™, Validated, Recombinant, 1.0 mg/mL
Host speciesRabbit
SpecificityBIRC2
ImmunogenA synthetic peptide derived from human cIAP1 (AA 29-42).
Positive ControlWB: HeLa, HUVEC, HT-29 and LNCaP cell lysates. IF/ICC: HeLa cells.
ConjugationUnconjugated
GradeExactAb™, Recombinant, Validated
Product Description

Rabbit anti Human cIAP1 Antibody, Recombinant, could be used for WB, IF/ICC and so on.
Application:
WB:1/500-1/2000
IF/ICC: 1/50-1/200

Protein Function:
Apoptotic suppressor. The BIR motifs region interacts with TNF receptor associated factors 1 and 2 (TRAF1 and TRAF2) to form an heteromeric complex, which is then recruited to the tumor necrosis factor receptor 2 (TNFR2).

Product Properties

IsotypeRabbit IgG
SDS-PAGE150 kDa
Purification MethodAntigen affinity purified
FormLiquid
Concentration1.0 mg/mL
Storage TempStore at -20°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at 4°C short term (1-2 weeks). Store at -20°C long term (24 months). Upon delivery aliquot. Avoid freeze/thaw cycle.

Images

Recombinant cIAP1 Antibody (Recombinant cIAP1 Antibody (Ab096509) - Western Blot
All lanes: Recombinant cIAP1 Antibody (Ab096509) at 1/2000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab170144) at 1/30000 dilution

Predicted band size: 70 kDa
Observed band size: 65 kDa
Exposure time: 284.5 s

Recombinant cIAP1 Antibody (Ab096509) - IF/ICC
Immunocytochemistry analysis of Ciap1 (green) in HeLa using Recombinant cIAP1 Antibody (Ab096509), and cells were counterstained with DAPI (blue). 

Associated Targets(Human)

BIRC2 Tchem Baculoviral IAP repeat-containing protein 2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
BIRC2 Tchem Baculoviral IAP repeat-containing protein 2 (984 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BIRC2 Tchem Baculoviral IAP repeat-containing protein 2/Hematopoietic prostaglandin D synthase (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Application

ApplicationDilution info
WB1/500-1/1000

">

1/500-1/1000

IF/ICC1/50 - 1/200

">

1/50 - 1/200

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

2 results found

Lot NumberCertificate TypeDateItem
ZJ24F0303170Certificate of AnalysisMar 13, 2024 Ab096509
ZJ24F0303169Certificate of AnalysisMar 13, 2024 Ab096509

Related Documents

References

1. Gyrd-Hansen M, Meier P.  (2010)  IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer..  Nat Rev Cancer,  10  (8): (561-74).  [PMID:20651737] [10.1021/op500134e]
2. Allensworth JL, Sauer SJ, Lyerly HK, Morse MA, Devi GR.  (2013)  Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism..  Breast Cancer Res Treat,  137  (2): (359-71).  [PMID:23225169] [10.1021/op500134e]
3. Cai Q, Sun H, Peng Y, Lu J, Nikolovska-Coleska Z, McEachern D, Liu L, Qiu S, Yang CY, Miller R et al..  (2011)  A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment..  J Med Chem,  54  (8): (2714-26).  [PMID:21443232] [10.1021/op500134e]
4. Flygare JA, Beresini M, Budha N, Chan H, Chan IT, Cheeti S, Cohen F, Deshayes K, Doerner K, Eckhardt SG et al..  (2012)  Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152)..  J Med Chem,  55  (9): (4101-13).  [PMID:22413863] [10.1021/op500134e]
5. Donnell AF, Michoud C, Rupert KC, Han X, Aguilar D, Frank KB, Fretland AJ, Gao L, Goggin B, Hogg JH et al..  (2013)  Benzazepinones and benzoxazepinones as antagonists of inhibitor of apoptosis proteins (IAPs) selective for the second baculovirus IAP repeat (BIR2) domain..  J Med Chem,  56  (20): (7772-87).  [PMID:24083782] [10.1021/op500134e]
6. Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P, Zobel K, Dynek JN, Elliott LO, Wallweber HJ et al..  (2007)  IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis..  Cell,  131  (4): (669-81).  [PMID:18022362] [10.1021/op500134e]
7. Todd D Taylor,Hideki Noguchi,Yasushi Totoki,Atsushi Toyoda,Yoko Kuroki,Ken Dewar,Christine Lloyd,Takehiko Itoh,Tadayuki Takeda,Dae-Won Kim,Xinwei She,Karen F Barlow,Toby Bloom,Elspeth Bruford,Jean L Chang,Christina A Cuomo,Evan Eichler,Michael G FitzGerald,David B Jaffe,Kurt LaButti,Robert Nicol,Hong-Seog Park,Christopher Seaman,Carrie Sougnez,Xiaoping Yang,Andrew R Zimmer,Michael C Zody,Bruce W Birren,Chad Nusbaum,Asao Fujiyama,Masahira Hattori,Jane Rogers,Eric S Lander,Yoshiyuki Sakaki.  (2006-03-24)  Human chromosome 11 DNA sequence and analysis including novel gene identification..  Nature,  440  ((7083)): (497-500).  [PMID:16554811]
8. Zhang B, Nikolovska-Coleska Z, Zhang Y, Bai L, Qiu S, Yang CY, Sun H, Wang S, Wu Y..  (2008)  Design, synthesis, and evaluation of tricyclic, conformationally constrained small-molecule mimetics of second mitochondria-derived activator of caspases..  J Med Chem,  51  (23): (7352-7355).  [PMID:19012392] [10.1021/jm801146d]
9. Sun W, Nikolovska-Coleska Z, Qin D, Sun H, Yang CY, Bai L, Qiu S, Wang Y, Ma D, Wang S..  (2009)  Design, synthesis, and evaluation of potent, nonpeptidic mimetics of second mitochondria-derived activator of caspases..  J Med Chem,  52  (3): (593-596).  [PMID:19138149] [10.1021/jm801101z]
10. Cohen F, Alicke B, Elliott LO, Flygare JA, Goncharov T, Keteltas SF, Franklin MC, Frankovitz S, Stephan JP, Tsui V, Vucic D, Wong H, Fairbrother WJ..  (2009)  Orally bioavailable antagonists of inhibitor of apoptosis proteins based on an azabicyclooctane scaffold..  J Med Chem,  52  (6): (1723-1730).  [PMID:19228017] [10.1021/jm801450c]
11. Sun H, Liu L, Lu J, Qiu S, Yang CY, Yi H, Wang S..  (2010)  Cyclopeptide Smac mimetics as antagonists of IAP proteins..  Bioorg Med Chem Lett,  20  (10): (3043-3046).  [PMID:20443226] [10.1016/j.bmcl.2010.03.114]
12. Sun H, Liu L, Lu J, Bai L, Li X, Nikolovska-Coleska Z, McEachern D, Yang CY, Qiu S, Yi H, Sun D, Wang S..  (2011)  Potent bivalent Smac mimetics: effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity..  J Med Chem,  54  (9): (3306-3318).  [PMID:21462933] [10.1021/jm101651b]
13. Sheng R, Sun H, Liu L, Lu J, McEachern D, Wang G, Wen J, Min P, Du Z, Lu H, Kang S, Guo M, Yang D, Wang S..  (2013)  A potent bivalent Smac mimetic (SM-1200) achieving rapid, complete, and durable tumor regression in mice..  J Med Chem,  56  (10): (3969-3979).  [PMID:23651223] [10.1021/jm400216d]
14. Kester RF, Donnell AF, Lou Y, Remiszewski SW, Lombardo LJ, Chen S, Le NT, Lo J, Moliterni JA, Han X, Hogg JH, Liang W, Michoud C, Rupert KC, Mischke S, Le K, Weisel M, Janson CA, Lukacs CM, Fretland AJ, Hong K, Polonskaia A, Gao L, Li S, Solis DS, Aguilar D, Tardell C, Dvorozniak M, Tannu S, Lee EC, Schutt AD, Goggin B..  (2013)  Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domain..  J Med Chem,  56  (20): (7788-7803).  [PMID:24093940] [10.1021/jm400732v]
15. Perez HL, Chaudhry C, Emanuel SL, Fanslau C, Fargnoli J, Gan J, Kim KS, Lei M, Naglich JG, Traeger SC, Vuppugalla R, Wei DD, Vite GD, Talbott RL, Borzilleri RM..  (2015)  Discovery of potent heterodimeric antagonists of inhibitor of apoptosis proteins (IAPs) with sustained antitumor activity..  J Med Chem,  58  (3): (1556-1562).  [PMID:25584393] [10.1021/jm501482t]
16. Demizu Y, Shibata N, Hattori T, Ohoka N, Motoi H, Misawa T, Shoda T, Naito M, Kurihara M..  (2016)  Development of BCR-ABL degradation inducers via the conjugation of an imatinib derivative and a cIAP1 ligand..  Bioorg Med Chem Lett,  26  (20): (4865-4869).  [PMID:27666635] [10.1016/j.bmcl.2016.09.041]
17. Tamanini E, Buck IM, Chessari G, Chiarparin E, Day JEH, Frederickson M, Griffiths-Jones CM, Hearn K, Heightman TD, Iqbal A, Johnson CN, Lewis EJ, Martins V, Peakman T, Reader M, Rich SJ, Ward GA, Williams PA, Wilsher NE..  (2017)  Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP)..  J Med Chem,  60  (11): (4611-4625).  [PMID:28492317] [10.1021/acs.jmedchem.6b01877]
18. Shibata N, Nagai K, Morita Y, Ujikawa O, Ohoka N, Hattori T, Koyama R, Sano O, Imaeda Y, Nara H, Cho N, Naito M..  (2018)  Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein Ligands..  J Med Chem,  61  (2): (543-575).  [PMID:28594553] [10.1021/acs.jmedchem.7b00168]
19. Baggio C, Gambini L, Udompholkul P, Salem AF, Aronson A, Dona A, Troadec E, Pichiorri F, Pellecchia M..  (2018)  Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach..  J Med Chem,  61  (14): (6350-6363).  [PMID:29940121] [10.1021/acs.jmedchem.8b00810]
20. Yokoo H,Shibata N,Naganuma M,Murakami Y,Fujii K,Ito T,Aritake K,Naito M,Demizu Y.  (2021)  Development of a Hematopoietic Prostaglandin D Synthase-Degradation Inducer..  ACS Med Chem Lett,  12  (2): (236-241).  [PMID:33603969] [10.1021/acsmedchemlett.0c00605]
21. Rothe, M M, Pan, M G MG, Henzel, W J WJ, Ayres, T M TM and Goeddel, D V DV..  (1995)  The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins..  Cell,    (29):   [PMID:8548810]
22. Liston, P P and 10 more authors..  (1996)  Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes..  Nature,    (25):   [PMID:8552191]
23. Uren, A G AG, Pakusch, M M, Hawkins, C J CJ, Puls, K L KL and Vaux, D L DL..  (1996)  Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors..  Proceedings of the National Academy of Sciences of the United States of America,    (14):   [PMID:8643514]
24. Hinds, M G MG, Norton, R S RS, Vaux, D L DL and Day, C L CL..  (1999)  Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat..  Nature structural biology,      [PMID:10404221]
25. Samuel, Temesgen T and 5 more authors..  (2005)  cIAP1 Localizes to the nuclear compartment and modulates the cell cycle..  Cancer research,    (1):   [PMID:15665297]
26. Zobel, Kerry K and 10 more authors..  (2006)  Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs..  ACS chemical biology,    (19):   [PMID:17168540]
27. Xu, Lei L and 7 more authors..  (2007)  c-IAP1 cooperates with Myc by acting as a ubiquitin ligase for Mad1..  Molecular cell,    (14):   [PMID:18082613]
28. Dubrez-Daloz, Laurence L, Dupoux, Alban A and Cartier, Jessy J..  (2008)  IAPs: more than just inhibitors of apoptosis proteins..  Cell cycle (Georgetown, Tex.),    (15):   [PMID:18414036]
29. Dephoure, Noah N and 6 more authors..  (2008)  A quantitative atlas of mitotic phosphorylation..  Proceedings of the National Academy of Sciences of the United States of America,    (5):   [PMID:18669648]
30. Sun, M M, Song, L L, Li, Y Y, Zhou, T T and Jope, R S RS..  (2008)  Identification of an antiapoptotic protein complex at death receptors..  Cell death and differentiation,      [PMID:18846110]
31. Kulathila, Raviraj R and 8 more authors..  (2009)  The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9..  Acta crystallographica. Section D, Biological crystallography,      [PMID:19153467]
32. Ndubaku, Chudi C and 15 more authors..  (2009)  Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists..  ACS chemical biology,    (17):   [PMID:19492850]
33. Mayya, Viveka V and 7 more authors..  (2009)  Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions..  Science signaling,    (18):   [PMID:19690332]
34. Lopez, Juanita J and Meier, Pascal P..  (2010)  To fight or die - inhibitor of apoptosis proteins at the crossroad of innate immunity and death..  Current opinion in cell biology,      [PMID:20888210]
35. Damgaard, Rune B RB and Gyrd-Hansen, Mads M..  (2011)  Inhibitor of apoptosis (IAP) proteins in regulation of inflammation and innate immunity..  Discovery medicine,      [PMID:21447281]
36. Lopez, Juanita J and 10 more authors..  (2011)  CARD-mediated autoinhibition of cIAP1's E3 ligase activity suppresses cell proliferation and migration..  Molecular cell,    (10):   [PMID:21549626]
37. Cartier, Jessy J and 12 more authors..  (2011)  Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 transcription factor-mediated control of cyclin transcription..  The Journal of biological chemistry,    (29):   [PMID:21653699]
38. Mei, Yide Y, Hahn, Allison Alcivar AA, Hu, Shimin S and Yang, Xiaolu X..  (2011)  The USP19 deubiquitinase regulates the stability of c-IAP1 and c-IAP2..  The Journal of biological chemistry,    (14):   [PMID:21849505]
39. Bertrand, Mathieu J M MJ and 8 more authors..  (2011)  cIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4)..  PloS one,      [PMID:21931591]
40. Darding, M M and Meier, P P..  (2012)  IAPs: guardians of RIPK1..  Cell death and differentiation,      [PMID:22095281]
41. Zhou, Alicia Y AY and 6 more authors..  (2013)  IKKε-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex..  Cell reports,    (28):   [PMID:23453969]
42. Synoradzki, Kamil K and Bieganowski, Pawel P..  (2015)  Middle domain of human Hsp90 isoforms differentially binds Aha1 in human cells and alters Hsp90 activity in yeast..  Biochimica et biophysica acta,      [PMID:25486457]
43. Wang, Yu-Bo YB and 13 more authors..  (2015)  Ubiquitin-associated domain-containing ubiquitin regulatory X (UBX) protein UBXN1 is a negative regulator of nuclear factor κB (NF-κB) signaling..  The Journal of biological chemistry,    (17):   [PMID:25681446]
44. Anderson NA, Cryan J, Ahmed A, Dai H, McGonagle GA, Rozier C, Benowitz AB..  (2020)  Selective CDK6 degradation mediated by cereblon, VHL, and novel IAP-recruiting PROTACs..  Bioorg Med Chem Lett,  30  (9): (127106-127106).  [PMID:32184044] [10.1016/j.bmcl.2020.127106]

Solution Calculators